GEM-X Universal 5' Gene Expression v3, 16 Samples
SAM.GOV Due: May 16, 2025 at 02:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The opportunity titled 'GEM-X Universal 5' Gene Expression v3, 16 Samples' is a combined synopsis/solicitation issued by the National Institutes of Health (NIH) under the National Institute of Allergy and Infectious Diseases (NIAID). This procurement is focused on acquiring specific reagents from 10X Genomics that are essential for ongoing clinical trials involving the isolation and sequencing of plasmablasts from blood samples. The contractor will be responsible for providing the GEM-X Single Cell 5' Gene Expression v3 reagents, which are critical for maintaining the integrity and viability of the samples for downstream analysis. Businesses with experience in biological product manufacturing, particularly those familiar with 10X Genomics products, are encouraged to bid on this opportunity, as the requirement includes a brand name restriction to ensure consistency in research methodologies.
Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commerci

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325414
Set Aside
None
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
RITA DAVIS [email protected] 3017617461 primary
Tonia Alexander [email protected] 2406695124 secondary
Attachments
  • RFQ-NIAID-25-2260513_Terms_and_Conditions_FAR_52.212-5.pdf